511 related articles for article (PubMed ID: 32184320)
21. Glycosyltransferases and glycosaminoglycans in bleomycin and transforming growth factor-β1-induced pulmonary fibrosis.
Venkatesan N; Tsuchiya K; Kolb M; Farkas L; Bourhim M; Ouzzine M; Ludwig MS
Am J Respir Cell Mol Biol; 2014 Mar; 50(3):583-94. PubMed ID: 24127863
[TBL] [Abstract][Full Text] [Related]
22. Indirubin alleviates bleomycin-induced pulmonary fibrosis in mice by suppressing fibroblast to myofibroblast differentiation.
Wang Q; Yu J; Hu Y; Chen X; Zhang L; Pan T; Miao K; Mou Y; Xu Y; Xiong W; Wang Y
Biomed Pharmacother; 2020 Nov; 131():110715. PubMed ID: 32927253
[TBL] [Abstract][Full Text] [Related]
23. Metformin attenuates lung fibrosis development via NOX4 suppression.
Sato N; Takasaka N; Yoshida M; Tsubouchi K; Minagawa S; Araya J; Saito N; Fujita Y; Kurita Y; Kobayashi K; Ito S; Hara H; Kadota T; Yanagisawa H; Hashimoto M; Utsumi H; Wakui H; Kojima J; Numata T; Kaneko Y; Odaka M; Morikawa T; Nakayama K; Kohrogi H; Kuwano K
Respir Res; 2016 Aug; 17(1):107. PubMed ID: 27576730
[TBL] [Abstract][Full Text] [Related]
24. Aggravation of pulmonary fibrosis after knocking down the aryl hydrocarbon receptor in the insulin-like growth factor 1 receptor pathway.
Wu SM; Tsai JJ; Pan HC; Arbiser JL; Elia L; Sheu ML
Br J Pharmacol; 2022 Jul; 179(13):3430-3451. PubMed ID: 35083738
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of miR-182-5p attenuates pulmonary fibrosis via TGF-β/Smad pathway.
Chen Y; Zhang Q; Zhou Y; Yang Z; Tan M
Hum Exp Toxicol; 2020 May; 39(5):683-695. PubMed ID: 31884830
[TBL] [Abstract][Full Text] [Related]
26. Protective role of rhapontin in experimental pulmonary fibrosis in vitro and in vivo.
Tao L; Cao J; Wei W; Xie H; Zhang M; Zhang C
Int Immunopharmacol; 2017 Jun; 47():38-46. PubMed ID: 28364627
[TBL] [Abstract][Full Text] [Related]
27. PEDF is an antifibrosis factor that inhibits the activation of fibroblasts in a bleomycin-induced pulmonary fibrosis rat model.
Qin X; Jia C; Liang J; Chen J; Liu X; Chao Z; Qin H; Yuan Y; Liu Z; Zhang Z; Dong H; Zhang H
Respir Res; 2022 Apr; 23(1):100. PubMed ID: 35459189
[TBL] [Abstract][Full Text] [Related]
28. Sphingosine Kinase 1/S1P Signaling Contributes to Pulmonary Fibrosis by Activating Hippo/YAP Pathway and Mitochondrial Reactive Oxygen Species in Lung Fibroblasts.
Huang LS; Sudhadevi T; Fu P; Punathil-Kannan PK; Ebenezer DL; Ramchandran R; Putherickal V; Cheresh P; Zhou G; Ha AW; Harijith A; Kamp DW; Natarajan V
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192225
[TBL] [Abstract][Full Text] [Related]
29. Increased deposition of chondroitin/dermatan sulfate glycosaminoglycan and upregulation of β1,3-glucuronosyltransferase I in pulmonary fibrosis.
Venkatesan N; Ouzzine M; Kolb M; Netter P; Ludwig MS
Am J Physiol Lung Cell Mol Physiol; 2011 Feb; 300(2):L191-203. PubMed ID: 21056957
[TBL] [Abstract][Full Text] [Related]
30. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
Mou F; Mou C
Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
[TBL] [Abstract][Full Text] [Related]
31. Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3.
Mackinnon AC; Gibbons MA; Farnworth SL; Leffler H; Nilsson UJ; Delaine T; Simpson AJ; Forbes SJ; Hirani N; Gauldie J; Sethi T
Am J Respir Crit Care Med; 2012 Mar; 185(5):537-46. PubMed ID: 22095546
[TBL] [Abstract][Full Text] [Related]
32. MUC1 intracellular bioactivation mediates lung fibrosis.
Milara J; Ballester B; Montero P; Escriva J; Artigues E; Alós M; Pastor-Clerigues A; Morcillo E; Cortijo J
Thorax; 2020 Feb; 75(2):132-142. PubMed ID: 31801904
[TBL] [Abstract][Full Text] [Related]
33. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY
Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376
[TBL] [Abstract][Full Text] [Related]
34. Role of lung ornithine aminotransferase in idiopathic pulmonary fibrosis: regulation of mitochondrial ROS generation and TGF-β1 activity.
Lee JU; Song KS; Hong J; Shin H; Park E; Baek J; Park S; Baek AR; Lee J; Jang AS; Kim DJ; Chin SS; Kim UJ; Jeong SH; Park SW
Exp Mol Med; 2024 Feb; 56(2):478-490. PubMed ID: 38413821
[TBL] [Abstract][Full Text] [Related]
35. Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-β receptor I internalization and inhibiting transforming growth factor-β1 signaling.
Shi Y; Gochuico BR; Yu G; Tang X; Osorio JC; Fernandez IE; Risquez CF; Patel AS; Shi Y; Wathelet MG; Goodwin AJ; Haspel JA; Ryter SW; Billings EM; Kaminski N; Morse D; Rosas IO
Am J Respir Crit Care Med; 2013 Oct; 188(7):831-41. PubMed ID: 23924348
[TBL] [Abstract][Full Text] [Related]
36. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway.
Ruan H; Lv Z; Liu S; Zhang L; Huang K; Gao S; Gan W; Liu X; Zhang S; Helian K; Li X; Zhou H; Yang C
J Pharm Pharmacol; 2020 Jan; 72(1):44-55. PubMed ID: 31659758
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of Sulf2 in idiopathic pulmonary fibrosis.
Yue X; Lu J; Auduong L; Sides MD; Lasky JA
Glycobiology; 2013 Jun; 23(6):709-19. PubMed ID: 23418199
[TBL] [Abstract][Full Text] [Related]
38. CG223, a novel BET inhibitor, exerts TGF-β1-mediated antifibrotic effects in a murine model of bleomycin-induced pulmonary fibrosis.
Kaneshita S; Kida T; Yoshioka M; Nishioka K; Raje M; Sakashita A; Hirano A; Sagawa T; Kasahara A; Inoue T; Fujioka K; Nagahara H; Wada M; Kohno M; Strovel JW; Fletcher S; Ashihara E; Kawahito Y
Pulm Pharmacol Ther; 2021 Oct; 70():102057. PubMed ID: 34425215
[TBL] [Abstract][Full Text] [Related]
39. B Cells Are Not Involved in the Regulation of Adenoviral TGF-β1- or Bleomycin-Induced Lung Fibrosis in Mice.
Moog MT; Hinze C; Bormann T; Aschenbrenner F; Knudsen L; DeLuca DS; Jonigk D; Neubert L; Welte T; Gauldie J; Kolb M; Maus UA
J Immunol; 2022 Mar; 208(5):1259-1271. PubMed ID: 35149532
[TBL] [Abstract][Full Text] [Related]
40. Protein tyrosine phosphatase-α amplifies transforming growth factor-β-dependent profibrotic signaling in lung fibroblasts.
Aschner Y; Nelson M; Brenner M; Roybal H; Beke K; Meador C; Foster D; Correll KA; Reynolds PR; Anderson K; Redente EF; Matsuda J; Riches DWH; Groshong SD; Pozzi A; Sap J; Wang Q; Rajshankar D; McCulloch CAG; Zemans RL; Downey GP
Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L294-L311. PubMed ID: 32491951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
